| Recruiting | BDB-001 Phase III Trial in ANCA-Associated Vasculitis ANCA Associated Vasculitis (AAV) | Phase 3 | 2025-11-10 |
| Recruiting | To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrom Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | 2025-10-31 |
| Recruiting | A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis Neurotrophic Keratitis | Phase 2 | 2025-06-12 |
| Recruiting | A Study to Evaluate the Safety and Tolerability of Multiple Dose of STSP-0902 in Healthy Subjects Oligozoospermia | Phase 1 | 2025-05-08 |
| Completed | A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects Neurotrophic Keratitis | Phase 1 | 2024-10-20 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Sub Oligozoospermia, Asthenozoospermia | Phase 1 | 2024-07-31 |
| Completed | Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor Hemophilia | Phase 2 | 2024-03-18 |
| Completed | To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | 2023-12-09 |
| Completed | The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects Primary Immune Thrombocytopenia | Phase 1 | 2023-11-16 |
| Completed | A Study of STSA-1201 in Healthy Subjects Healthy | Phase 1 | 2023-08-04 |
| Terminated | To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B Chronic Hepatitis b | Phase 2 | 2023-04-25 |
| Terminated | Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B Chronic Hepatitis b | Phase 2 | 2023-04-25 |
| Completed | The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects Antineutrophil Cytoplasmic Antibody Associated Vasculitis | Phase 1 | 2023-01-31 |
| Completed | Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor Hemophilia | Phase 2 | 2023-01-09 |
| Terminated | A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects Healthy Subject | Phase 1 | 2022-11-08 |
| Completed | A Study of STSA-1002 in Healthy Subjects Healthy Subject | Phase 1 | 2022-10-14 |
| Completed | Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil C ANCA-associated Vasculitis | Phase 1 / Phase 2 | 2022-02-22 |
| Completed | The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects Healthy | Phase 1 | 2022-01-10 |
| Completed | A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor Hemophilia | Phase 1 / Phase 2 | 2021-10-12 |
| Completed | The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects Healthy | Phase 1 | 2021-09-28 |
| Completed | Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (H Hidradenitis Suppurativa | Phase 2 | 2021-08-18 |
| Completed | Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (H Hidradenitis Suppurativa | Phase 1 / Phase 2 | 2021-06-24 |
| Terminated | Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS COVID-19 Pneumonia | Phase 2 / Phase 3 | 2020-07-23 |
| Completed | Tolerability and Safety of BDB-001 Injection in Healthy Subjects Healthy | Phase 1 | 2020-03-12 |
| Terminated | A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients COVID-19 | Phase 1 | 2020-02-21 |
| Completed | A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor Hemophilia | Phase 1 | 2020-01-15 |
| Completed | Safety and Tolerability of BDB-001 Injection in Healthy Subjects Healthy | Phase 1 | 2019-09-25 |